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The urine-blood PCO2 gradient as a diagnostic index of H+-
ATPase defect distal renal tubular acidosis.
Background. Urine pH during acidemia and urine PCO2
upon alkalization both may be useful to indicate H+ secretion
from collecting ducts. The urine anion gap has been used to de-
tect urinary NH4
+ for differential diagnosis of hyperchloremic
metabolic acidosis. We have previously demonstrated that the
lack of normal H+-ATPase may underlie secretory defect distal
renal tubular acidosis (dRTA). In this study we evaluated the
diagnostic value of the urine-blood (U-B) PCO2 in H
+-ATPase
defect dRTA, and compared it with that of urine pH and urine
anion gap during acidemia.
Methods. In H+-ATPase defect dRTA, the diagnostic values
of three urinary parameters were evaluated: (1) urine pH mea-
sured after acid (NH4Cl) loading; (2) urine-to-blood carbon
dioxide tension gradient (U-B PCO2) during alkali (NaHCO3)
loading; and (3) urine anion gap during acidemia. Seventeen
patients were diagnosed as having H+-ATPase defect dRTA
based on reduced urinary NH4
+ and an absolute decrease in H+-
ATPase immunostaining in intercalated cells on renal biopsy.
Eight patients with non-dRTA renal disease served as control
patients.
Results. Upon NaHCO3 loading, U-B PCO2 was ≤30 mm
Hg in all 17 dRTA patients and >30 mm Hg in all 8 control
patients. With NH4Cl loading, urine pH was >5.4 in 15 of 17
dRTA patients and ≤5.4 in 7 of 8 control patients, and the
urine anion gap was >5 mmol/L in 13 of 17 dRTA patients and
≤5 mmol/L in 6 of 8 control patients. Therefore, the sensitiv-
ity and specificity of U-B PCO2 ≤30 mm Hg during NaHCO3
loading were both 100%, whereas those of urine pH >5.4 or
urine anion gap >5 mmol/L during NH4Cl loading were below
90%. In control patients, the U-B PCO2 was found to be well
correlated with the urinary NH4
+ (r = 0.79, P < 0.05).
Conclusion. The U-B PCO2 during NaHCO3 loading is an
excellent diagnostic index of H+-ATPase defect dRTA.
Key words: renal tubular acidosis, H+-ATPase, sodium bicarbonate
loading, urine PCO2.
Received for publication July 19, 2003
and in revised form January 15, 2004
Accepted for publication March 9, 2004
C© 2004 by the International Society of Nephrology
The minimum urine pH induced by NH4Cl load-
ing has traditionally been the main criterion for the
diagnosis of distal renal tubular acidosis (dRTA) [1].
However, urine pH during systemic acidosis may be a
misleading index for the assessment of metabolic acido-
sis because of the discrepancy between urine pH and uri-
nary NH4+ [2]. In acute acidosis, the rate of H+ secretion
exceeds that of ammonia. In chronic metabolic acidosis,
on the other hand, the increase in ammonia caused by
augmented ammoniagenesis is relatively larger than the
increase in H+ secretion [3]. In this context, the urine
anion gap was proposed to be useful in the diagnosis of
hyperchloremic metabolic acidosis [4]. In addition, the
NH4Cl loading test has a difficulty in clinical practice; oral
NH4Cl frequently causes gastric irritation, and liver dis-
ease is a contraindication to the administration of NH4Cl
[5].
Previous studies have assessed H+ secretion from col-
lecting ducts by measuring the urine-to-blood carbon
dioxide tension gradient (U-B PCO2) after NaHCO3
loading [6–10]. Urine PCO2 with alkalization is a mea-
sure of the capacity of the proton pump to maximally
secrete H+ because alkaline urine provides a favorable
gradient for H+ secretion [5]. According to Batlle et al
[8], the inability to raise urine PCO2 normally during
NaHCO3 loading may be the most sensitive index of de-
creased distal urinary acidification. DuBose et al [9, 10]
have demonstrated that U-B PCO2 is an adequate quali-
tative index of distal nephron H+ secretion in the normal
rat and in a variety of experimental animal models of
dRTA.
Recently we demonstrated that the lack of normal
H+-ATPase in intercalated cells may underlie the previ-
ously classified secretory defect dRTA [11, 12]. This study
was undertaken to evaluate the diagnostic efficacy of U-
B PCO2 during NaHCO3 loading in H+-ATPase defect
dRTA versus urine pH and the urine anion gap during
acidemia.
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METHODS
Patients
Seventeen adult patients with H+-ATPase defect
dRTA were enrolled in this study. The diagnosis of
H+-ATPase defect dRTA was based on overt hyper-
chloremic metabolic acidosis accompanied with an ab-
solute decrease in H+-ATPase immunostaining in inter-
calated cells on renal biopsy and a low level of urinary
NH4+ (<50 mmol/L). All patients were hypokalemic or
normokalemic (<5.5 mmol/L). The causes of dRTA were
idiopathic, tubulointerstitial nephropathies, and autoim-
mune disorders like Sjo¨gren’s syndrome. Eight patients
with renal diseases but without any defect in urinary acid-
ification served as control patients, and these included 3
patients taking percutaneous renal biopsy for glomeru-
lar or tubulointerstitial disease and 5 patients undergo-
ing surgical nephrectomy due to renal cell carcinoma. All
patients were enrolled after obtaining informed consent.
Urinary acidification tests
Acid (NH4Cl) and alkali (NaHCO3) loading tests were
performed as previously described [12]. In the NH4Cl
loading test, the NH4Cl was administered orally at a
dosage of 0.2 g/kg of body weight, and urine was collected
under mineral oil at 2-hour intervals from 4 to 8 hours
for the determination of NH4+, pH, and urine anion gap.
The ammonium chloride loading test was omitted in case
of overt acidemia (plasma HCO3− <18 mmol/L). Urine
NH4+ was determined by the enzymatic method [13], and
urine pH was measured using a pH meter (Beckman,
Fullerton, CA, USA). Urine electrolytes were measured
on an autoanalyzer (Beckman) to calculate the urine an-
ion gap (Na+ + K+ − Cl−).
In the NaHCO3 loading test, 2.75% NaHCO3 solu-
tion was infused intravenously at a rate of 4 mL/kg/hour.
Urine and blood samples were taken at 2-hour inter-
vals until the plasma bicarbonate concentration reached
26 mmol/L. Urine and blood PCO2 were measured using
a blood gas analyzer (Nova, Waltham, MA, USA), and
the U-B PCO2 was calculated when the urine pH was
raised to 7.5.
Immunohistochemistry of renal tissues
Tissues from percutaneous renal biopsy or surgi-
cal nephrectomy were preserved in periodate-lysine-
paraformaldehyde. Fixed tissues were dehydrated and
embedded in polyester wax, sectioned at 4 lm, and
mounted on gelatin-coated glass slides. The sections were
dewaxed with xylene and ethanol, and then treated with
methanolic H2O2 for 30 minutes after rinsing under tap
water. Before incubation with primary antibody, the sec-
tions were permeabilized by incubation for 15 minutes in
phosphate-buffered saline (PBS) containing 0.5% Triton
X-100, and then blocked with normal goat serum diluted
1:10 in PBS for 15 minutes. Subsequently, the sections
were incubated overnight at 4◦C with a rabbit polyclonal
antibody to the 70-kd catalytic subunit of the vacuolar
H+-ATPase (kindly provided by Dr. Dennis Stone, Uni-
versity of Texas Southwestern, Dallas, TX, USA). Sec-
tions were then rinsed in PBS, incubated with biotinylated
secondary antibody for 60 minutes, and then with Vectas-
tain ABC reagent (Vector Laboratories, Burlingame, CA,
USA) for 60 minutes. After being rinsed with 0.1 mol/L
Tris buffer, the sections were incubated in a mixture of
0.05% 3.3′-diaminobenzidine and 0.033% H2O2 for 1 to
2 minutes at room temperature. After being rinsed with
Tris buffer again, the sections were counterstained with
hematoxylin and examined under an optical microscope.
Statistical analysis
The results of the urinary acidification tests were ana-
lyzed using SPSS version 10.0 for Windows (Chicago, IL,
USA). Data are presented as mean ± SEM. The dRTA
patients and control patients were compared using the
Mann-Whitney U test. Correlations between variables of
interest were analyzed by linear regression. P < 0.05 was
considered as indicative of statistical significance. Diag-
nostic performance was expressed in terms of sensitivity,
specificity, positive and negative predictive values, and as
the area under receiver operating characteristic (ROC)
curves.
RESULTS
In all of the 17 dRTA patients, renal biopsy tissues re-
vealed an absolute decrease in the immunostaining of
H+-ATPase along the connecting tubules and the collect-
ing ducts. In contrast, the immunostaining of H+-ATPase
was strongly positive on the apical membranes of type A
intercalated cells in renal tissues from controls (Fig. 1).
Table 1 shows the baseline data and results of urinary
acidification tests, which compare the H+-ATPase defect
dRTA patients with control patients. The urine data from
NH4Cl loading were obtained when the urine pH was
minimally decreased. As expected, dRTA patients had a
lower urine NH4+ concentration and higher urine pH and
urine anion gap than the control patients. With NaHCO3
loading, dRTA patients had a significantly lower U-B
PCO2 than the control patients (1.5 ± 3.1 vs. 53.2 ±
1.6 mm Hg, P < 0.001).
Next, we tried to find out the best cut-off point for
each urinary index to discriminate dRTA patients from
controls. Table 2 and Figure 2 show the trade-off between
the sensitivity and the specificity. The value lying nearest
to the point of intersection of the ROC curve, and the
100% to 100% diagonal was chosen as the best cut-off
point: (1) in the NaHCO3 loading test, 30 mm Hg for
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Fig. 1. H+-ATPase immunohistochemistry of renal cortex from distal
renal tubular acidosis (dRTA) patient and control patient. In dRTA pa-
tients, H+-ATPase immunoreactivity was almost absent in intercalated
cells. In contrast, numerous intercalated cells with apical H+-ATPase
immunostaining (arrows) are observed in connecting tubule (CNT) and
cortical collecting duct (CCD). Weak H+-ATPase immunostaining is
noted in the subapical region of proximal convoluted tubule (PCT).
Magnifications, × 400.
Table 1. Results of urinary acidification tests
dRTA (N = 17) Control (N = 8) P value
Baseline data
pH 7.27 ± 0.01 7.42 ± 0.01 <0.001
HCO3− mEq/L 15.4 ± 1.32 24.9 ± 0.15 <0.001
Serum K mEq/L 3.38 ± 0.21 4.68 ± 0.14 <0.001
NH4Cl loading
Urine NH4
+ mmol/L 24.9 ± 1.4 75.3 ± 2.7 <0.001
Urine pH 6.3 ± 0.2 5.2 ± 0.1 <0.001
Urine AG mmol/L 14.0 ± 2.9 −9.6 ± 5.4 0.002
NaHCO3 loading
U-B PCO2 mm Hg 1.5 ± 3.1 53.2 ± 1.6 <0.001
Abbreviations are: dRTA, distal renal tubular acidosis; urine AG, urine
anion gap; U-B PCO2, urine-to-blood carbon dioxide tension gradient. Data
are expressed as mean values ± SEM. The urine data from NH4Cl loading
were obtained when urine pH was minimally decreased. NH4Cl loading test
was omitted in case of overt academia (plasma HCO3− <18 mmol/L). The U-B
PCO2 was calculated when urine pH was raised to 7.5. P value was estimated by
using Mann-Whitney U test.
U-B PCO2; (2) in the NH4Cl loading test, 5.4 for urine
pH and 5 mmol/L for urine anion gap. With NaHCO3
loading, the U-B PCO2 was ≤30 mm Hg in all 17 dRTA
patients and >30 mm Hg in all 8 control patients.
With NH4Cl loading, the urine pH was >5.4 in 15 of
17 dRTA patients and ≤5.4 in 7 of 8 control patients.
The urine anion gap was >5 mmol/L in 13 of 17 dRTA
patients and ≤5 mmol/L in 6 of 8 control patients. There-
fore, the sensitivity and specificity of U-B PCO2 ≤30 mm
Hg during NaHCO3 loading were both 100%. Both the
positive and negative predictive values at this point were
also 100%. In contrast, the sensitivity and specificity of
urine pH >5.4 during NH4Cl loading were calculated as
88.2% and 87.5%, respectively, with associated positive
and negative predictive values of 93.8 and 77.8%, respec-
Table 2. Sensitivity and specificity of the U-B PCO2 after NaHCO3
loading, and the urine pH and urine anion gap after NH4Cl loading at
various cut-off points to diagnose H+-ATPase defect distal renal
tubular acidosis
Cut-off point Sensitivity (%) Specificity (%)
U-B PCO2 mm Hg 20.0 100 94.4
30.0 100 100
40.0 100 100
50.0 87.5 100
Urine pH 5.2 100 62.5
5.3 94.1 75
5.4 88.2 87.5
5.5 82.4 87.5
5.6 76.5 100
Urine anion gap −5.0 100 62.5
mmol/L 0.0 82.4 62.5
5.0 76.5 75
10.0 64.7 100
0.5
0.6
0.7
0.8
0.9
1.0
Se
ns
itiv
ity
0.0 0.1 0.2 0.3 0.4 0.5
1 – Specificity
Alkali loading
Acid loading (UpH)
Acid loading (UAG)
Fig. 2. Comparison of receiver operating characteristic curves for
NaHCO3 loading test and NH4Cl loading test in H
+-ATPase defect
distal renal tubular acidosis patients and control patients (dotted line
represents the 100% to 100% diagonal). UpH, urine pH; UAG, urine
anion gap.
tively. The sensitivity and specificity of urine anion gap
>5 mmol/L during NH4Cl loading were 76.5 and 75%,
respectively, and the corresponding positive and negative
predictive values were 86.7 and 60%, respectively.
When the ROC curves were analyzed from these uri-
nary indices, the area under the ROC curve was 1.00 (95%
CI 1.00–1.00) for the U-B PCO2, 0.96 (95% CI 0.89–1.03)
for the urine pH, and 0.90 (95% CI 0.77–1.02) for the
urine anion gap (Fig. 2).
As shown in Figure 3, the H+-ATPase defect dRTA
patients and control patients were clearly discriminated
by urine NH4+ and U-B PCO2. However, urine pH
or urine anion gap values overlapped in some of the
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Fig. 3. Distribution of the urine NH4
+ after NH4Cl loading and the
urine-to-blood PCO2 gradient (U-B PCO2) after NaHCO3 loading
in H+-ATPase defect distal renal tubular acidosis patients (rectangles)
and control patients (triangles). The subjects could be distinctly divided
into the H+-ATPase defect dRTA patients and the controls using a 30
mm Hg U-B PCO2 cut-off level.
H+-ATPase defect dRTA patients and the control pa-
tients (Fig. 4). We also found a positive correlation be-
tween the urinary NH4+ after NH4Cl loading and the
U-B PCO2 after NaHCO3 loading in control patients
(r = 0.79, P = 0.019; Fig. 5). Although urine pH and urine
anion gap seemed to be correlated inversely with urine
NH4+, there were no statistical significances (Fig. 6).
DISCUSSION
We have demonstrated the excellent diagnostic ef-
ficacy of U-B PCO2 during NaHCO3 loading test in
H+-ATPase defect dRTA, which was defined as hyper-
chloremic metabolic acidosis with an absolute decrease
in H+-ATPase immunostaining in intercalated cells and
a low urinary NH4+. U-B PCO2 during NaHCO3 load-
ing has proved more useful to diagnose H+-ATPase de-
fect dRTA than urine pH and the urine anion gap during
acidemia. When we tested the sensitivities and specifici-
ties of the three urinary indices to diagnose H+-ATPase
defect dRTA, the best results were obtained using U-B
PCO2 during NaHCO3 loading. The subjects could be
distinctly divided into the H+-ATPase defect dRTA pa-
tients and the normal when we applied the U-B PCO2
cut-off level obtained in this study. Additionally, there
was the best correlation between the urinary NH4+ after
NH4Cl loading and the U-B PCO2 after NaHCO3 load-
ing in control patients.
We showed that there was a positive correlation be-
tween the urinary NH4+ and the U-B PCO2 in control
patients (r = 0.79, P = 0.019; Fig. 5), not in the whole
cases. However, the urinary NH4+ and the U-B PCO2
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Fig. 4. Distribution of the urine NH4
+ and the urine pH (A) and the
urine NH4
+ and the urine anion gap (B) after NH4Cl loading in H
+-
ATPase defect distal renal tubular acidosis patients (rectangles) and
control patients (triangles). Some of the H+-ATPase defect dRTA pa-
tients shared a certain range of urine pH or urine anion gap with the
control patients using 5.4 urine pH or 5 mmol/L urine anion gap cut-off
level.
was not on a linear correlation in group of dRTA patients.
This may be because ammonium loading was not done in
some of the dRTA patients whose bicarbonate level was
below 18 mEq/L. Moreover, the rise of urine ammonium
excretion in response to the acid loading can be different
between the cases of acute acidosis (such as the control
patients) and the chronic acidosis (dRTA patients) [2], so
we showed the correlations in only the control patients.
Although discriminator values are usually determined
by undefined procedures, we tried to find out the best
cut-off point by ROC curve analysis. According to the
results shown in Table 2, both 30 and 40 mm Hg could be
reasonable cut-off points. Arbitrarily we chose the former
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Fig. 5. Correlation between the urine NH4
+ after NH4Cl loading and
the urine-to-blood PCO2 gradient (U-B PCO2) after NaHCO3 loading
in control patients.
as the more reasonable cut-off point because that was
utilized more commonly.
In ROC curve analysis, the 95% CI for the area of the
three urinary indices does not include the 0.5 value. All of
them have ability to distinguish between two groups. In
comparison with U-B PCO2 to the others, discrimination
capacity of U-B PCO2 seemed to be superior to that of
urine pH and urine anion gap because the area of the
former was larger than the rest. However, there was no
confirmed output in statistics because sample size was not
large enough to have significant conclusions.
Ammonium chloride loading test is informative only
in cases of incomplete dRTA and mild hyperchloremic
metabolic acidosis where no diagnosis can be made. In
this study, 5 subjects of the dRTA group were incomplete
dRTA and urine acidification test was done in only these
patients and control patients. A dose of NH4Cl (0.1g/kg
body weight) was an adequate stimulus to produce these
acid urines [14]. Actually, we administered NH4Cl on a
dosage of 0.2 g/kg of body weight, which was two times
compared to that of Wrong’s theory [14], to both groups
in the NH4Cl loading test. Moreover, in all the subjects
in whom ammonium loading test were done, bicarbonate
level was lowered sufficiently and urinary NH4+ appar-
ently discriminated between each of groups. So, we think
that the dosage is sufficient. In case of those patients who
have acidemia already in whom NH4Cl loading is not nec-
essary, urinary pH does not always bring accurate gauge
of acidification, and an evaluation of net acid excretion is
often necessary [5].
The combination of urinary pH and urine anion gap
could be considered as another diagnostic index. But we
could get no additive information because three false neg-
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Fig. 6. Correlation between the urine NH4
+ and the urine pH (A) and
the urine NH4
+ and the urine anion gap (B) after NH4Cl loading in
control patients.
ative patients through urinary pH in dRTA patients were
included in four false negative patients through urine an-
ion gap in the same group, and the correlation between
urinary NH4+ and the combination of both of them has
no statistical significance.
There is a subset of patients with a subtle defect in distal
acidification. These patients cannot raise the urine PCO2
in response to a HCO3− load, but can lower urine pH to
<5.5 in response to an acid load [8, 15]. Kurtzman termed
this disorder “rate-dependent dRTA” [16]. His reasoning
was that the urine PCO2 reflected the rate of distal acidi-
fication, and that a moderate decrease in that rate might
be reflected only by decreased urine PCO2 [16]. Batlle
et al suggested that rate-dependent dRTA could be used
to classify conditions that involve a reduced rate of H+
secretion in the collecting duct, not because of primary
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proton pump failure, but because of the reduced availabil-
ity of intracellular H+, a failure to sustain an adequate
transtubular electrical gradient, aldosterone deficiency,
or aldosterone resistance [17]. However, our results do
not support this notion. Of 17 patients with H+-ATPase
defect dRTA, three patients mentioned above lowered
their urine pH <5.5 with a urine anion gap <0 mmol/L
after NH4Cl loading, but could not raise the U-B PCO2 to
≥30 mm Hg after NaHCO3 loading. Thus, these patients
could be regarded as “rate-dependent dRTA.” Neverthe-
less, they also showed an absolute decrease in H+ ATPase
immunostaining in intercalated cells. We suspect that pro-
ton pump may not be intact in rate-dependent dRTA, and
that primary proton pump failure may have a role in this
subset of dRTA patients.
So, the U-B PCO2 during NaHCO3 loading may re-
flect the activity of distal nephron H+-ATPase as well as
urinary NH4+ secretion. Although the minimal urine pH
achieved during acidosis is a measure of the force of the
proton pump and the urine anion gap is a valuable index
of NH4+ secretion [4, 5], U-B PCO2 during NaHCO3
loading is a better indicator of H+-ATPase defect dRTA.
Jordan et al [18] reported that the immunohistochemi-
cal evidence for reduced H+-ATPase was paralleled by
urinary PCO2 response to NaHCO3 loading in a study
of six kidney transplant recipients. Moreover, the bicar-
bonate loading test offers additional information in terms
of determining whether proximal acidification is also im-
paired by allowing calculation of the fractional excretion
of HCO3−.
On the other hand, we cannot say that a low U-B PCO2
during NaHCO3 loading is equivalent to H+-ATPase
defect dRTA. The presence of H+-ATPase staining in
intercalated cells does not necessarily reflect the nor-
mal functional status of H+-ATPase [19]. Voltage defect
dRTA, for instance, has been reported to preserve H+-
ATPase in intercalated cells despite a low U-B PCO2
during NaHCO3 loading [20]. Examples of voltage-
dependent defects in collecting tubule acidification due
to an isolated impairment of sodium transport are so
far confined to obstructive uropathy, salt-losing congen-
ital adrenal hyperplasia, and administration of lithium,
amiloride, trimethoprim, and pentamidine. So, although
U-B PCO2 is also abnormal in the voltage defect dRTA,
we can usually differentiate it with the H+-ATPase
defect RTA relatively easily from the history and clin-
ical situations of the patients and the presence of hy-
perkalemia. Unfortunately, we didn’t have the cases of
voltage-dependent dRTA in this study.
Serum potassium level was reduced in 8 of the 17 dRTA
patients. Hypokalemia may influence the urinary NH4+
excretion because it increases NH3 and NH4+ produc-
tion in the renal tubular cells. However, in this study
serum potassium level was restored to normal range be-
fore the loading tests, and the urinary NH4+ excretion
was reduced in all of the hypokalemic dRTA patients,
so the effect of hypokalemia on the urinary NH4+ ex-
cretion could be neglected. Hypokalemia is presumably
due to increased distal potassium secretion, possibly me-
diated by secondary hyperaldosteronism and increased
distal delivery of sodium or defect in H+-K+-ATPase.
Although there is a speculation that hypokalemic dRTA
is fundamentally different from normokalemic dRTA in
that the defect is in the H+-K+-ATPase instead of the H+-
ATPase [16, 21], this possibility remains highly theoreti-
cal because this transporter is more implicated in K+ than
in H+ homeostasis [22]. Nevertheless, the role of H+-K+-
ATPase function in the hypokalemic dRTA should not be
overlooked because this transporter’s deficient function
to vanadium toxicity has been suggested to be the cause
of the environmental hypokalemic dRTA present in Thai-
land [23]. Unfortunately, we could not test the possible
role of a deficiency of H+-K+-ATPase as the mechanism
underlying hypokalemic dRTA because of the lack of an-
tibodies. This hypothesis remains to be evaluated in the
future study.
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